Efficacy and safety of carfilzomib, lenalidomide, and dexamethasone versus ixazomib, lenalidomide, and dexamethasone in real world patients with relapsed/refractory multiple myeloma: KMM2004 study

Clinical Lymphoma, Myeloma & Leukemia(2023)

Cited 0|Views16
No score
Key words
multiple myeloma,relapsed/refractory multiple myeloma,lenalidomide,ixazomib,dexamethasone
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined